Martin E. Cearnal

Insider Reports History

Location
Montclair, NJ
Signature
Martin E. Cearnal /s/ John Hamm as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin E. Cearnal:

Company Role Class Num Shares Value Price $ Report Date Ownership
CUMBERLAND PHARMACEUTICALS INC Sr VP/Chief Commercial Officer, Director Common Stock 163,473 $277,904 $1.70 17 Mar 2022 Direct
CUMBERLAND PHARMACEUTICALS INC Sr VP/Chief Commercial Officer, Director Options (right to buy) 0 17 Mar 2022 Direct

Insider Reports Filed by Martin E. Cearnal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CPIX CUMBERLAND PHARMACEUTICALS INC 17 Mar 2022 2 -$41,100 4 Sr VP/Chief Commercial Officer, Director 29 Apr 2022, 13:11
CPIX CUMBERLAND PHARMACEUTICALS INC 01 Dec 2021 14 +$9,571 4 Sr VP/Chief Commercial Officer, Director 07 Jan 2022, 16:07
CPIX CUMBERLAND PHARMACEUTICALS INC 01 Nov 2021 21 +$6,803 4 Sr VP/Chief Commercial Officer, Director 03 Dec 2021, 16:05
CPIX CUMBERLAND PHARMACEUTICALS INC 01 Oct 2021 21 +$5,999 4 Sr VP/Chief Commercial Officer, Director 05 Nov 2021, 17:15
CPIX CUMBERLAND PHARMACEUTICALS INC 01 Sep 2021 21 +$6,238 4 Sr VP/Chief Commercial Officer, Director 01 Oct 2021, 17:07
CPIX CUMBERLAND PHARMACEUTICALS INC 02 Aug 2021 21 +$6,567 4 Sr VP/Chief Commercial Officer, Director 10 Sep 2021, 17:03
CPIX CUMBERLAND PHARMACEUTICALS INC 30 Jun 2021 22 +$7,505 4 Sr VP/Chief Commercial Officer, Director 13 Aug 2021, 17:10
CPIX CUMBERLAND PHARMACEUTICALS INC 18 May 2021 30 +$9,495 4 Sr VP/Chief Commercial Officer, Director 09 Jul 2021, 17:10
CPIX CUMBERLAND PHARMACEUTICALS INC 17 Mar 2021 26 +$27,022 4 Sr VP/Chief Commercial Officer, Director 08 Jun 2021, 17:22